Sense Neuro Diagnostics develops non-invasive brain scanners that utilize low-power radio frequency pulses to assess and monitor neurological conditions in real time. Their technology enables rapid differentiation of stroke subtypes and traumatic brain injuries, addressing the critical need for timely and accurate field assessments to improve patient outcomes.
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for detecting stroke subtype and brain hemorrhage in pre-hospital environments or for continuous monitoring of brain injury are lacking, relying on subjective clinical exams, vital signs, and intermittent CT/MRI scans. Delays in accurate diagnosis and triage can lead to disability and death.
Solution
Sense Neuro Diagnostics is developing non-invasive brain scanning technology that utilizes low-power radio frequency (RF) pulses to rapidly assess and monitor neurological conditions in real time. The technology aims to differentiate between stroke subtypes, including intracerebral hemorrhage (ICH) and large vessel occlusion (LVO), as well as detect intracerebral hemorrhages related to traumatic brain injury (TBI). The device scans the entire cranial vault in 2.5 seconds, analyzing 360 data points per scan to identify changes in RF signal caused by different brain tissues and pathologies. This enables rapid triage and assessment in emergency departments, ambulances, and field environments, as well as continuous hospital monitoring to improve patient outcomes.
Target Audience
The primary target audience includes medical personnel in emergency departments, ambulances, and military field environments, as well as neurologists and neurocritical care specialists in hospitals.
Features
- Non-invasive brain scanning using low-power radio frequency (RF) pulses
- Rapid scan time of 2.5 seconds for the entire cranial vault
- Analysis of 360 data points per scan to detect changes in brain tissue properties
- Differentiation between stroke subtypes (ICH, LVO, non-LVO)
- Detection of intracerebral hemorrhages related to traumatic brain injury (TBI)
- Designed for field assessment, emergency department triage, and continuous hospital monitoring
- Clinical trials underway for FDA clearance